Discover the full record of transactions filed by Fraser Craig, Chairman & CEO. Officer active across 1 companies, notably Windtree Therapeutics INC. Cumulatively, 12 reports have been logged. Total volume traded: €32k. The latest transaction was disclosed on 29 June 2022 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
Craig Fraser is the President and CEO of WINDTREE THERAPEUTICS INC. He leads the company's operations and oversees the implementation of its development strategy, contributing to innovation in the biotechnology sector.